These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 7528205)

  • 1. Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue.
    Stan R; McLaughlin MM; Cafferkey R; Johnson RK; Rosenberg M; Livi GP
    J Biol Chem; 1994 Dec; 269(51):32027-30. PubMed ID: 7528205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missense mutations at the FKBP12-rapamycin-binding site of TOR1.
    Freeman K; Livi GP
    Gene; 1996 Jun; 172(1):143-7. PubMed ID: 8654975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue.
    Chen J; Zheng XF; Brown EJ; Schreiber SL
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4947-51. PubMed ID: 7539137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin.
    Lorenz MC; Heitman J
    J Biol Chem; 1995 Nov; 270(46):27531-7. PubMed ID: 7499212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells.
    Sabers CJ; Martin MM; Brunn GJ; Williams JM; Dumont FJ; Wiederrecht G; Abraham RT
    J Biol Chem; 1995 Jan; 270(2):815-22. PubMed ID: 7822316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FKBP12-rapamycin target TOR2 is a vacuolar protein with an associated phosphatidylinositol-4 kinase activity.
    Cardenas ME; Heitman J
    EMBO J; 1995 Dec; 14(23):5892-907. PubMed ID: 8846782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs.
    Sabatini DM; Erdjument-Bromage H; Lui M; Tempst P; Snyder SH
    Cell; 1994 Jul; 78(1):35-43. PubMed ID: 7518356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rapamycin and FKBP12 target (RAFT) displays phosphatidylinositol 4-kinase activity.
    Sabatini DM; Pierchala BA; Barrow RK; Schell MJ; Snyder SH
    J Biol Chem; 1995 Sep; 270(36):20875-8. PubMed ID: 7673106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin.
    Zheng XF; Florentino D; Chen J; Crabtree GR; Schreiber SL
    Cell; 1995 Jul; 82(1):121-30. PubMed ID: 7606777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex.
    Chiu MI; Katz H; Berlin V
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12574-8. PubMed ID: 7809080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian RAFT1 kinase domain provides rapamycin-sensitive TOR function in yeast.
    Alarcon CM; Cardenas ME; Heitman J
    Genes Dev; 1996 Feb; 10(3):279-88. PubMed ID: 8595879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity.
    Cafferkey R; Young PR; McLaughlin MM; Bergsma DJ; Koltin Y; Sathe GM; Faucette L; Eng WK; Johnson RK; Livi GP
    Mol Cell Biol; 1993 Oct; 13(10):6012-23. PubMed ID: 8413204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase activity and identification of a toxic effector domain of the target of rapamycin TOR proteins in yeast.
    Alarcon CM; Heitman J; Cardenas ME
    Mol Biol Cell; 1999 Aug; 10(8):2531-46. PubMed ID: 10436010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fission yeast TOR homolog, tor1+, is required for the response to starvation and other stresses via a conserved serine.
    Weisman R; Choder M
    J Biol Chem; 2001 Mar; 276(10):7027-32. PubMed ID: 11096119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mammalian protein targeted by G1-arresting rapamycin-receptor complex.
    Brown EJ; Albers MW; Shin TB; Ichikawa K; Keith CT; Lane WS; Schreiber SL
    Nature; 1994 Jun; 369(6483):756-8. PubMed ID: 8008069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FAP1, a homologue of human transcription factor NF-X1, competes with rapamycin for binding to FKBP12 in yeast.
    Kunz J; Loeschmann A; Deuter-Reinhard M; Hall MN
    Mol Microbiol; 2000 Sep; 37(6):1480-93. PubMed ID: 10998178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control.
    Loewith R; Jacinto E; Wullschleger S; Lorberg A; Crespo JL; Bonenfant D; Oppliger W; Jenoe P; Hall MN
    Mol Cell; 2002 Sep; 10(3):457-68. PubMed ID: 12408816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin antifungal action is mediated via conserved complexes with FKBP12 and TOR kinase homologs in Cryptococcus neoformans.
    Cruz MC; Cavallo LM; Görlach JM; Cox G; Perfect JR; Cardenas ME; Heitman J
    Mol Cell Biol; 1999 Jun; 19(6):4101-12. PubMed ID: 10330150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin.
    Cardenas ME; Zhu D; Heitman J
    Curr Opin Nephrol Hypertens; 1995 Nov; 4(6):472-7. PubMed ID: 8591053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP.
    Choi J; Chen J; Schreiber SL; Clardy J
    Science; 1996 Jul; 273(5272):239-42. PubMed ID: 8662507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.